Academic Journal
Urease promotes pH homeostasis and growth of Staphylococcus aureus in skin-like conditions.
| Title: | Urease promotes pH homeostasis and growth of Staphylococcus aureus in skin-like conditions. |
|---|---|
| Authors: | Costa FG; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Horswill AR; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Department of Veterans Affairs, Eastern Colorado Healthcare System, Aurora, Colorado, USA. |
| Source: | Journal of bacteriology [J Bacteriol] 2025 Oct 23; Vol. 207 (10), pp. e0020825. Date of Electronic Publication: 2025 Sep 08. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. |
| Language: | English |
| Journal Info: | Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 2985120R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-5530 (Electronic) Linking ISSN: 00219193 NLM ISO Abbreviation: J Bacteriol Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Washington, DC : American Society for Microbiology |
| MeSH Terms: | Urease*/metabolism , Urease*/genetics , Skin*/microbiology , Staphylococcus aureus*/growth & development , Staphylococcus aureus*/enzymology , Staphylococcus aureus*/metabolism , Methicillin-Resistant Staphylococcus aureus*/growth & development , Methicillin-Resistant Staphylococcus aureus*/enzymology , Methicillin-Resistant Staphylococcus aureus*/metabolism , Methicillin-Resistant Staphylococcus aureus*/genetics , Homeostasis*, Bacterial Proteins/metabolism ; Bacterial Proteins/genetics ; Urea/metabolism ; Ammonia/metabolism ; Hydrogen-Ion Concentration ; Humans |
| Abstract: | Staphylococcus aureus is a Gram-positive opportunistic pathogen and a leading cause of skin and soft tissue infections (SSTIs). S. aureus colonizes approximately 20-30% of the population and transiently colonizes the skin. Although skin colonization is an SSTI risk factor, our understanding of S. aureus requirements to persist in this environment is still developing. The human skin is acidic, with a ubiquitous distribution of eccrine glands, which secrete metabolites, such as urea onto the skin surface. Many pathogens break down urea into ammonia and carbon dioxide by the Ni(II)-dependent enzyme urease as an acid resistance mechanism. S. aureus relies on urea metabolism for pH homeostasis in the murine kidney, but a role for this process on skin has not been shown. Using an in vitro model of the human skin surface environment, we investigated the role of urease in the methicillin-resistant USA300 strain S. aureus subsp. aureus (MRSA) LAC. We observe that urease contributes to an increase in extracellular pH and production of extracellular ammonium, which results in ammonium becoming a shared good in a mixed culture. We also demonstrate that the putative urea transporter SAUSA300_2237 (ureT) is required for optimal extracellular ammonia generation. Finally, we show that the urease inhibitor fluorofamide effectively inhibits S. aureus urease activity. This work identifies a role for urea metabolism during S. aureus skin colonization and offers the first published characterization of the S. aureus putative urea transporter, UreT.IMPORTANCEThe human skin is a unique microbial environment that has been challenging to faithfully model in the laboratory. Here, we utilize a recently developed media recipe incorporating metabolites measured from healthy human skin to assess the role of urease in Staphylococcus aureus pH homeostasis in the skin environment. These data provide new insights into the role of urea metabolism in S. aureus pH homeostasis during skin colonization. We also describe the first characterization of transporter SAUSA300_2237 (ureT) and demonstrate its role in urea metabolism. These insights advance our understanding of this metabolic pathway in S. aureus. |
| Competing Interests: | The authors declare no conflict of interest. |
| References: | Temperature (Austin). 2019 Jul 17;6(3):211-259. (PMID: 31608304) Microbiology (Reading). 2003 Nov;149(Pt 11):3289-3297. (PMID: 14600241) Vet Pathol. 2012 Jan;49(1):146-54. (PMID: 22135020) Int J Mol Sci. 2024 Aug 23;25(17):. (PMID: 39273114) Infect Immun. 2025 Apr 08;93(4):e0002825. (PMID: 40116525) PLoS Pathog. 2019 Jan 4;15(1):e1007538. (PMID: 30608981) mBio. 2013 Feb 12;4(1):e00537-12. (PMID: 23404398) Front Microbiol. 2015 Jul 28;6:767. (PMID: 26284049) Mol Microbiol. 2020 Jan;113(1):103-122. (PMID: 31618469) Infect Immun. 1998 Oct;66(10):4832-7. (PMID: 9746586) Sci Rep. 2019 Nov 28;9(1):17789. (PMID: 31780805) Sci Rep. 2019 Nov 13;9(1):16663. (PMID: 31723175) Helicobacter. 2001 Jun;6(2):93-9. (PMID: 11422463) mBio. 2024 May 8;15(5):e0045324. (PMID: 38546267) Nature. 2009 Dec 10;462(7274):757-61. (PMID: 19865084) PLoS One. 2012;7(7):e42244. (PMID: 22860095) Biotechnol Adv. 2015 Nov 15;33(7):1484-92. (PMID: 26057689) J Bacteriol. 2013 Feb;195(3):444-52. (PMID: 23104809) Gastroenterology. 1996 Oct;111(4):886-900. (PMID: 8831583) Dig Dis Sci. 1998 Jan;43(1):109-19. (PMID: 9508511) Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):20059-64. (PMID: 23169633) FEMS Microbiol Lett. 2024 Jan 9;371:. (PMID: 39567841) J Dermatol. 2018 Sep;45(9):1044-1052. (PMID: 29863755) Biochemistry. 2011 Oct 11;50(40):8656-63. (PMID: 21877689) mBio. 2012 Mar 20;3(2):. (PMID: 22434850) mSphere. 2016 Jun 15;1(3):. (PMID: 27340697) Nat Commun. 2024 May 15;15(1):4062. (PMID: 38750035) Gastroenterology. 2002 Jul;123(1):187-95. (PMID: 12105847) Cell Rep. 2021 Mar 30;34(13):108924. (PMID: 33789094) J Biol Inorg Chem. 2020 Sep;25(6):829-845. (PMID: 32809087) Acta Derm Venereol. 2013 May;93(3):261-7. (PMID: 23322028) Anal Biochem. 1966 Jul;16(1):132-8. (PMID: 4290701) J Bacteriol. 2010 Jan;192(1):94-103. (PMID: 19854893) Int J Cosmet Sci. 2006 Oct;28(5):359-70. (PMID: 18489300) mBio. 2017 Feb 14;8(1):. (PMID: 28196956) Microbiology (Reading). 2019 Feb;165(2):197-207. (PMID: 30566075) Appl Environ Microbiol. 2007 May;73(9):3091-4. (PMID: 17351089) Lancet Infect Dis. 2005 Dec;5(12):751-62. (PMID: 16310147) Lett Appl Microbiol. 2014 Jan;58(1):31-41. (PMID: 24001038) Int J Cosmet Sci. 2013 Oct;35(5):477-83. (PMID: 23713991) N Engl J Med. 2001 Jan 4;344(1):11-6. (PMID: 11136954) Clin Infect Dis. 2015 May 15;60(10):1489-96. (PMID: 25648237) Cell Host Microbe. 2013 Jan 16;13(1):100-7. (PMID: 23332159) Clin Microbiol Rev. 1997 Jul;10(3):505-20. (PMID: 9227864) Int J Biometeorol. 1991 Nov;35(3):180-6. (PMID: 1778649) PLoS One. 2010 Apr 14;5(4):e10146. (PMID: 20418950) J Bacteriol. 2014 Jun;196(12):2277-89. (PMID: 24727224) Cell Rep. 2025 Mar 25;44(3):115421. (PMID: 40085646) PLoS One. 2010 Nov 30;5(11):e15520. (PMID: 21152088) Infect Immun. 1989 Jan;57(1):110-6. (PMID: 2909483) J Innate Immun. 2010;2(6):576-86. (PMID: 20829609) |
| Grant Information: | R01 AI162964 United States AI NIAID NIH HHS; AI153185 National Institute of Allergy and Infectious Diseases; AI172080 National Institute of Allergy and Infectious Diseases; BX002711 U.S. Department of Veterans Affairs |
| Contributed Indexing: | Keywords: Staphylococcus aureus; acid tolerance; microbial physiology; pH homeostasis; skin colonization; urease |
| Substance Nomenclature: | EC 3.5.1.5 (Urease) 0 (Bacterial Proteins) 8W8T17847W (Urea) 7664-41-7 (Ammonia) |
| Entry Date(s): | Date Created: 20251023 Date Completed: 20251023 Latest Revision: 20260714 |
| Update Code: | 20260714 |
| PubMed Central ID: | PMC12548400 |
| DOI: | 10.1128/jb.00208-25 |
| PMID: | 41128611 |
| Database: | MEDLINE |
Be the first to leave a comment!